ArticleGenetics2026
Uncertainty-aware breeding decisions: MCMC-based optimum contribution selection increases breeding decision robustness.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Optimum contribution selection (OCS) balances genetic gain and inbreeding by optimizing parental contributions to the next generation, but current implementations rely on point estimates of breeding values that discard the uncertainty inherent in genetic evaluations. We introduce CVaR-OCS, a novel formulation that incorporates the full posterior distribution of estimated breeding values (EBVs) directly into the OCS objective via Conditional Value at Risk (CVaR) (a coherent risk measure from financial portfolio theory) allowing a single optimization to simultaneously maximize expected genetic gain and protect against worst-case outcomes driven by EBV uncertainty. We evaluate CVaR-OCS on a simulated multi-generation genomic selection dataset with known true breeding values (QTL-MAS 2010; n=3,226), enabling direct comparison to an oracle solution, and on Norway spruce (Picea abies n=5,525) and Loblolly pine (Pinus taeda n=926) forest tree breeding progeny trials, with consistent tail-gain protection observed across all three datasets. On the simulated dataset, point-estimate MAP-OCS recovered only 78% of the genetic gain achieved by an oracle solution with access to true breeding values, illustrating the cost of ignoring predictive uncertainty; CVaR-OCS attained comparable expected gain while improving tail-gain security (CVaR95+0.69%) and recovering an additional oracle-optimal individual. In Norway spruce, the recommended CVaR-OCS operating point improved tail-gain security by 6.60% and broadened the selection base from 145 to 159 individuals at a genetic gain cost of only 0.70%. Complementary MCMC-based robustness scores revealed that 25 MAP-OCS selections in Norway spruce were unstable across the posterior distribution; post-hoc exclusion of these individuals failed to improve tail-gain security, motivating the principled CVaR-OCS approach. CVaR-OCS provides breeders with a principled, computationally efficient tool for uncertainty-aware selection decisions, and multi-generation simulation studies are needed to fully characterize its long-term effects on genetic gain trajectories and inbreeding accumulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.